It is hypothesized that activation of procalpain may render WAS patients more susceptible to enhanced cleavage of CD43 and gp115, thereby partially disrupting cell cytoskeleton morphology resembling characteristic features found in individuals affected by this syndrome [40]. This evidence concerns the gene SPN and Wiskott-Aldrich syndrome.